home / stock / aplt / aplt news

APLT News and Press, Applied Therapeutics Inc. From 09/24/20

Stock Information
Company Name: Applied Therapeutics Inc.
Stock Symbol: APLT
Market: NYSE
Website: appliedtherapeutics.com
Menu
APLT APLT Quote APLT Short APLT News APLT Articles APLT Message Board
Get APLT Alerts

News, Short Squeeze, Breakout and More Instantly...
APLT - FDA Grants AT-007 Pediatric Rare Disease Designation and Orphan Designation for Treatment of PMM2-CDG

NEW YORK, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that the ...
APLT - Applied Therapeutics to Present Data on AT-001 for Treatment of Diabetic Cardiomyopathy at 56th Annual Meeting of the European Association for the Study of Diabetes

NEW YORK, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will ...

APLT - Applied Therapeutics to Present at Citi and Baird Investor Conferences

NEW YORK, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will ...

APLT - THMO, OSTK, MBOT and UBX among midday movers

Gainers:  Comstock Mining (NYSEMKT: LODE ) +128% . More news on: Comstock Mining Inc., RISE Education Cayman Ltd, IMARA Inc., Stocks on the move, , Read more ...

APLT - Applied Therapeutics under pressure on FDA partial hold on key study

Applied Therapeutics (NASDAQ: APLT ) discloses that the FDA placed a partial clinical hold on its ACTION-Kids Study on August 14 citing the need for additional technical information related to ensuring that every participant in the study has access to the drug's benefits. It says it will...

APLT - Applied Therapeutics EPS misses by $0.56

Applied Therapeutics (NASDAQ: APLT ) : Q2 GAAP EPS of -$1.27 misses by $0.56 . Cash and cash equivalents and short-term investments totaled $138.5M. Press Release More news on: Applied Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news,

APLT - Applied Therapeutics Reports Second Quarter 2020 Financial Results

NEW YORK, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results fo...
APLT - Applied Therapeutics to Present Data on AT-007 for Treatment of Galactosemia at the Galactosemia Foundation 2020 Virtual Conference

NEW YORK, July 17, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced presentations coveri...

APLT - Applied Therapeutics Takes Action Against Fraudulent "Short Report"

On July 1, 2020, a fraudulent “short report” was posted. The fraudulent report includes manipulated company graphs and figures, fraudulent misrepresentation of data, and factual misstatements. Applied Therapeutics will work with law enforcement and regulators to ensur...

APLT - Applied Therapeutics reports additional 40mg/kg data from adult galactosemia study

Applied Therapeutics (NASDAQ: APLT ) announces additional supportive biomarker efficacy and safety data for AT-007 in Galactosemia at 40 mg/kg. More news on: Applied Therapeutics, Inc., Healthcare stocks news, Read more ...

Previous 10 Next 10